Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Clara Redondo

Trial Administrator


Clara joined the Early Phase Clinical Trials Unit as a Trial Administrator in March 2017. Prior to this she was a Postdoctoral researcher developing inhibitors for specific kinases selected as targets for therapeutic interventions, at the Structural Genomics Consortium in Oxford. Her current role in Clinical Trials mainly focuses on the set-up, activation and follow-up activities, amendment processing and team communications in a varied portfolio of Oncological and Haematological Trials.